US company petitions FDA to regulate all IVD tests
This article was originally published in RAJ Devices
Executive Summary
US biopharmaceutical company Genentech has filed a citizen petition with the Food and Drug Administration asking the agency to broaden the scope of its regulations to include in vitro diagnostic tests that are developed by clinical laboratory companies for in-house testing to guide therapeutic decision-making1.